Related Experiment Video
Updated: May 7, 2026

Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice
Published on: November 16, 2011
Incretin actions beyond the pancreas: lessons from knockout mice
1Division of Diabetes, Clinical Nutrition and Endocrinology, Kansai Electric Power Hospital, 2-1-7 Fukushima-ku, Osaka 553-0003, Japan; Division of Metabolism and Clinical Nutrition, Kansai Electric Power Hospital, 2-1-7 Fukushima-ku, Osaka 553-0003, Japan.
Glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) are key incretin hormones. Their receptors mediate glucose control and offer therapeutic potential for diabetes complications beyond the pancreas.
Area of Science:
- Endocrinology
- Metabolism
- Pharmacology
Background:
- Intestinal incretins, GIP and GLP-1, regulate insulin secretion post-nutrient intake.
- These hormones act via GIP receptor (GIPR) and GLP-1 receptor (GLP-1R) on pancreatic beta cells and other tissues.
- Understanding incretin receptor functions is crucial for metabolic disease research.
Purpose of the Study:
- To review recent findings on the extra-pancreatic effects of GIP and GLP-1.
- To explore the therapeutic implications of these incretins in diabetes treatment.
- To highlight the role of GIPR and GLP-1R in mediating diverse biological activities.
Main Methods:
- Review of recent scientific literature.
- Analysis of studies using GIPR and/or GLP-1R deficient mice models.
- Synthesis of data on incretin actions in various tissues and organs.
Main Results:
- GIP and GLP-1 enhance glucose-dependent insulin secretion.
- Incretin receptors are expressed in multiple tissues beyond the pancreas.
- Extra-pancreatic effects of GIP and GLP-1 are implicated in managing diabetes complications.
Conclusions:
- GIP and GLP-1 signaling pathways have significant roles in glucose homeostasis.
- Targeting GIPR and GLP-1R offers therapeutic avenues for diabetes and its comorbidities.
- Further research into extra-pancreatic incretin effects can advance diabetes care.
More Related Videos
07:44Surgical Injury to the Mouse Pancreas through Ligation of the Pancreatic Duct as a Model for Endocrine and Exocrine Reprogramming and Proliferation
Published on: August 7, 2015
10:09Leprdb Mouse Model of Type 2 Diabetes: Pancreatic Islet Isolation and Live-cell 2-Photon Imaging Of Intact Islets
Published on: May 11, 2015
Related Concept Videos
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
Insulin and C-peptide are co-secreted in...
In-vitro Mutagenesis